IP Library Granted Patent US 10,105,466
Granted Patent B2
US 10,105,466 · App. 14/257,261 · Granted Oct 23, 2018

Compositions with reactive ingredients, and wound dressings, apparatuses, and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,105,466
App. No.
14/257,261
Granted
Oct 23, 2018
Kind
B2
Abstract

Wound dressings and wound inserts comprising substantially dry reactive agents, methods of forming wound inserts comprising dry reactive agents, and wound-treatment methods.

Claims (10)

1. A wound treatment apparatus, comprising:

a wound insert comprising an open-celled foam;

a reactive agent disposed within the foam, and configured to be inert in the absence of an activating fluid and to exhibit antimicrobial properties in the presence of an activating fluid;

a drape configured to cover the wound insert; and

a fluid delivery pad configured to be coupled to the drape and a fluid source, wherein the fluid source is actuatable to deliver a fluid to a wound through the wound insert;

wherein the wound insert is configured to pass at least a portion of the reactive agent to a wound if the activating fluid is delivered to the wound insert.

2. The wound treatment apparatus of claim 1 , further comprising a vacuum source configured to be coupled to the wound insert such that the vacuum source is actuatable to apply negative pressure to the wound insert.

3. The wound treatment apparatus of claim 1 , wherein the reactive agent comprises a dry hypochlorite salt defined by M(OCl)n, where n=1 if M is K + , Li + , or Na + , and where n=2 if M is Ca 2+ or Mg 2+ .

4. The wound treatment apparatus of claim 1 , wherein the open-celled foam comprises a silicone foam having a porosity sufficient for communicating negative pressure.

5. The wound treatment apparatus of claim 4 , wherein the reactive agent comprises a dry hypochlorite salt defined by M(OCl)n, where n=1 if M is K + , Li + , or Na + , and where n=2 if M is Ca 2+ or Mg 2+ .

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066432/0345 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064730/0218 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2014
From: HONG, KZ, DR.; INGRAM, SHANNON C.; ZIMNITSKY, DMITRY; LONG, JUSTIN ALEXANDER; KAZALA, RICHARD M., JR.; RAMIREZ, HUGO
To: KCI LICENSING, INC.
Reel/Frame 034208/0247 →
Cited By (1)
US 12,685,798